1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Lung Cancer(NSCLC): new trials by email Literature Review of Lung Cancer(NSCLC) trials Research Report on Lung Cancer(NSCLC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors Tisotumab Vedotin (HuMax-TF-ADC) - Ovary Cancer, Cervix Cancer | Phase 1 / Phase 2 | Completed | Seagen Inc. | 195 | 2013-11-30 | 2021-12-29 |
Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Urinary Bladder Neoplasms (1) · Uterine Cervical Neoplasms (1)
Adnexal Diseases (1) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Esophageal Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Diseases, Male (1)
Seagen Inc. (1)
Belgium (1) · Denmark (1) · Sweden (1) · United Kingdom (1) · United States (1)